Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.06B |
| 2 |
Nasdaq
NDAQ
|
+$1.76B |
| 3 |
Wells Fargo
WFC
|
+$1.1B |
| 4 |
Gilead Sciences
GILD
|
+$978M |
| 5 |
Edwards Lifesciences
EW
|
+$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.75B |
| 3 |
HCA Healthcare
HCA
|
+$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 5 |
PNC Financial Services
PNC
|
+$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
ARS Pharmaceuticals
SPRY
$1.03B
| $2.35M | ﹤0.01% |
162,335
+45,452
| +39% | +$659K |
|
1427
Maplebear
CART
$11.8B
| $2.34M | ﹤0.01% |
57,383
-81,883
| -59% | -$3.34M |
|
1428
Orion Group Holdings
ORN
$296M
| $2.32M | ﹤0.01% |
+401,700
| New | +$2.32M |
|
|
RVNC
1429
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.31M | ﹤0.01% |
+446,027
| New | +$2.31M |
|
1430
Colony Bankcorp
CBAN
$297M
| $2.31M | ﹤0.01% |
149,147
| – | – |
|
1431
Krystal Biotech
KRYS
$3.97B
| $2.31M | ﹤0.01% |
12,680
+1,660
| +15% | +$302K |
|
1432
Corebridge Financial
CRBG
$17.8B
| $2.29M | ﹤0.01% |
78,488
+9,229
| +13% | +$269K |
|
1433
Arcturus Therapeutics
ARCT
$476M
| $2.23M | ﹤0.01% |
96,294
-264,455
| -73% | -$6.14M |
|
|
AAT
1434
American Assets Trust
AAT
$1.23B
| $2.23M | ﹤0.01% |
83,377
-200,768
| -71% | -$5.36M |
|
1435
Zoom
ZM
$25.1B
| $2.21M | ﹤0.01% |
31,742
-5,101
| -14% | -$356K |
|
1436
AnaptysBio
ANAB
$630M
| $2.21M | ﹤0.01% |
65,939
+3,048
| +5% | +$102K |
|
1437
Ulta Beauty
ULTA
$23B
| $2.19M | ﹤0.01% |
5,635
+710
| +14% | +$276K |
|
1438
CAE Inc
CAE
$8.43B
| $2.14M | ﹤0.01% |
114,025
+5,101
| +5% | +$95.9K |
|
1439
Dollar Tree
DLTR
$20.1B
| $2.14M | ﹤0.01% |
30,459
-961,497
| -97% | -$67.6M |
|
1440
Tyra Biosciences
TYRA
$651M
| $2.14M | ﹤0.01% |
90,825
-26,207
| -22% | -$616K |
|
1441
Applovin
APP
$191B
| $2.13M | ﹤0.01% |
16,352
-115,316
| -88% | -$15.1M |
|
1442
Coastal Financial
CCB
$1.67B
| $2.11M | ﹤0.01% |
39,120
| – | – |
|
1443
Aon
AON
$78B
| $2.09M | ﹤0.01% |
6,039
+4,812
| +392% | +$1.66M |
|
1444
DocuSign
DOCU
$15.9B
| $2.08M | ﹤0.01% |
33,508
-1,839
| -5% | -$114K |
|
1445
IQVIA
IQV
$31.9B
| $2.06M | ﹤0.01% |
8,685
-1,615,529
| -99% | -$383M |
|
1446
Immunome
IMNM
$817M
| $2.06M | ﹤0.01% |
140,690
+81,354
| +137% | +$1.19M |
|
|
EBTC
1447
DELISTED
Enterprise Bancorp
EBTC
| $2.04M | ﹤0.01% |
+63,923
| New | +$2.04M |
|
1448
Campbell Soup
CPB
$9.79B
| $2.03M | ﹤0.01% |
41,529
+921
| +2% | +$45.1K |
|
1449
Kura Sushi USA
KRUS
$953M
| $2.01M | ﹤0.01% |
25,000
-235,006
| -90% | -$18.9M |
|
|
ORKA
1450
Oruka Therapeutics, Inc. Common Stock
ORKA
$599M
| $2.01M | ﹤0.01% |
+82,137
| New | +$2.01M |
|